Total net sales (USD, thousands)

Cost of product sales (USD, thousands)

Cost of service sales (USD, thousands)

Selling and administrative expenses (USD, thousands)

Research and development expenses (USD, thousands)

Purchased intangibles amortization (USD, thousands)

Litigation provision (USD, thousands)

Total costs and operating expenses (USD, thousands)

Operating income (USD, thousands)

Other (expense) income, net (USD, thousands)

Interest expense (USD, thousands)

Interest income (USD, thousands)

Income before income taxes (USD, thousands)

Provision for income taxes (USD, thousands)

Net income (USD, thousands)

c3fe673c3a094e3fe4970a4bbfb9902d2532934b24772222b55a1b6f0299775a

Net income [USD, thousands]

Stock-based compensation [USD, thousands]

Depreciation [USD, thousands]

Amortization of intangibles [USD, thousands]

Decrease in accounts receivable [USD, thousands]

Increase in inventories [USD, thousands]

Decrease (increase) in other current assets [USD, thousands]

Increase in other assets [USD, thousands]

Increase (decrease) in accounts payable and other current liabilities [USD, thousands]

Increase in deferred revenue and customer advances [USD, thousands]

Decrease in other liabilities [USD, thousands]

Net cash provided by operating activities [USD, thousands]

Additions to property, plant, equipment and software capitalization [USD, thousands]

(Investments in) proceeds from unaffiliated companies [USD, thousands]

Purchases of investments [USD, thousands]

Maturities and sales of investments [USD, thousands]

Net cash used in investing activities [USD, thousands]

Payments on debt [USD, thousands]

Proceeds from stock plans [USD, thousands]

Purchases of treasury shares [USD, thousands]

Proceeds from derivative contracts [USD, thousands]

Net cash (used in) provided by financing activities [USD, thousands]

Effect of exchange rate changes on cash and cash equivalents [USD, thousands]

Decrease in cash and cash equivalents [USD, thousands]

Deferred income taxes [USD, thousands]

Cash and cash equivalents at beginning of period [USD, thousands]

Cash and cash equivalents at end of period [USD, thousands]

a9d7b86a1975f404b793efe595cd03bd71e3100d0336f046059e4f0958579133

Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Property, plant and equipment, net (USD, thousands)

Intangible assets, net (USD, thousands)

Goodwill (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Notes payable and debt (USD, thousands)

Total liabilities (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

2760dfeae2fe268e8528cdeff3a74c2fd9fbe30a26f191225107c1f4048c72f3

9f2a2258074aa0565ded28bf8a58114c9d60d9ff1c883ecb49086e0d2164cf9c

64ca8216905d9580b444fff2bf5e72655257710c6fc0d53f0c59093607f22c84

f1ae9f848b3273df78df8b3800bb8afa73a7e061b1c64d1b7ff82dd02aca15cf

Days sales outstanding (days)

Overall net sales growth from Wyatt acquisition (percentage)

Waters product and service sales growth from Wyatt acquisition (percentage)

Instrument system sales growth from Wyatt acquisition (percentage)

Service revenue growth from Wyatt acquisition (percentage)

Pharmaceutical sales growth from Wyatt acquisition (percentage)

Industrial sales growth from Wyatt acquisition (percentage)

Academic and government sales growth from Wyatt acquisition (percentage)

7aaba81a5e4c5442a78da923433be75acd1b353847b10ad0f47d9456a7dd428c

b1db5c974e8df64357010abc7474aeb5d2b24244e665583fae3c9097beaf2046

Waters Instrument Systems

Chemistry Consumables

TA Instrument Systems

- Total Product Sales

Waters Service

TA Service

- Total Service Sales

Total Revenue

ca329d086382c1099236b208a8ba751deb2cecc6e3992e270f3f66b7ee7bcebe

WATERS CORP /DE/ (WAT)

Financials